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Abstract
Background: Evidence linking risk of lymphoma and B-cell lymphoma subtypes to ionizing radiation is
inconclusive, particularly at low exposure levels.
Methods: We investigated risk of lymphoma (all subtypes), B-cell lymphomas, and its major subtypes, associated
with low-level occupational exposure to ionizing radiation, in 2346 lymphoma cases and 2463 controls, who
participated in the multicenter EpiLymph case-control study. We developed a job-exposure matrix to estimate
exposure to ionizing radiation, distinguishing between internal and external radiation, and we applied it to the
lifetime occupational history of study subjects, We calculated the Odds Ratio (OR) and its 95% confidence interval
(95% CI) for lymphoma (all subtypes combined), B-cell lymphoma, and its major subtypes using unconditional,
polytomous logistic regression adjusting for age, gender, and education.
Results: We did not observe an association between exposure metrics of external and internal radiation and risk of
lymphoma (all subtypes), nor with B-cell lymphoma, or its major subtypes, at the levels regularly experienced in
occupational settings. An elevated risk of diffuse large B cell lymphoma was observed among the most likely
exposed study subjects with relatively higher exposure intensity, which would be worth further investigation.
Conclusions: Further investigation is warranted on risk of B cell lymphoma subtypes associated with low-level
occupational exposure to external ionizing radiation, and to clarify whether lymphoma should be included among
the cancer outcomes related to ionizing radiation.
Keywords: Ionizing radiation, Lymphoma, Diffuse large B cell lymphoma, Occupational exposure
Introduction
The carcinogenic effects of ionizing radiation have been
extensively studied, and the association between human
exposure to high doses of ionizing radiation and risk of
solid tumours and leukemia is well-characterized [1]. As
it concerns hemolymphopoietic malignancies other than
leukemia, results are conflicting. Some studies reported
an increased risk of non Hodgkin Lymphoma (NHL)
among subjects with long-term repeated low-dose occu-
pational exposure to x-rays and γ-rays [2, 3], contrasting
previous reports [4, 5]. Results of cohort studies of radi-
ologists and radiology technicians were also inconsistent
[6, 7]. Instead, the Japanese A-bomb survivors, and
Chernobyl cleanup workers had a slight excess risk of
NHL and a significant excess of chronic lymphocytic
leukemia (CLL) [8–11]. A previous population based
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case-control study explored NHL risk in relation to oc-
cupational exposure to ionizing radiation first with a
standard job-exposure matrix (JEM) [12], and afterwards
using a local JEM created for the purpose [13]; in both
instances, the authors did not observe an association.
Another population-based case-control study was con-
ducted in Canada, which grouped the occupations by
binary categorization of several occupational exposures,
including radium, and uranium [14]: the results showed
a 2- to 3-fold excess risk of NHL associated with occu-
pations possibly involving such exposures, covering the
broad spectrum of ionizing radiation, from α to γ radi-
ation. As it concerns exposure to diagnostic x-ray proce-
dures, risk of chronic lymphocytic leukemia (CLL), and
non-Hodgkin Lymphoma (NHL) did not show an associ-
ation, while risk of multiple myeloma (MM) increased
with increasing number of diagnostic x-ray procedures
[15]. A recent study of exposure to diagnostic radiation,
based on the same data set we used for the present ana-
lysis, also did not corroborate the hypothesis of an in-
creased risk of lymphoma overall nor of any of its major
subtypes (Pasqual E et al. submitted). On the other hand,
NHL incidence increased with latency among patients
who underwent radiotherapy for non-small cell lung
cancer [16], and for ankylosing spondylitis [17].
A link between exposure to ionizing radiation and
lymphoma is plausible, as lymphocytes are highly radio-
sensitive; in fact, late damaging effects may show up
even after years of exposure to external ionizing radi-
ation [8, 18].
The study of cancer risk associated with exposure
to low-level ionizing radiation has attracted a great
deal of interest to establish whether a dose-response
curve keeps being visible at the current occupational
standards [19, 20]. Besides, the case-control studies
conducted thus far did not distinguish whether in-
ternal or external doses of ionizing radiation were
considered, which could have mislead the interpret-
ation of findings [12–14]. It has been suggested that
future epidemiological investigations should carefully
address such interpretative limitations [21].
The aim of our study was to explore the association
between occupational exposure to ionizing radiation and
major lymphoma subtypes, separately for external or in-
ternal radiation, in a population-based European multi-
center case-control study.
Materials and methods
Study population
The EpiLymph study is a multicenter case-control study
on lymphoma etiology, which was conducted in 1998–
2004 in six European Countries, namely Czech Republic,
France, Germany, Ireland, Italy, and Spain. A detailed
description of the study can be found elsewhere [22].
Briefly, eligible cases were all consecutive adult patients
first diagnosed with lymphoma during the study period,
resident in the referral area of the participating centers.
The diagnosis was classified according to the 2001
WHO classification of lymphoma [23]; slides of about
20% of cases from each centre were reviewed centrally
by a team of pathologists. Controls from Germany and
Italy were randomly selected from the general popula-
tion, frequency matched to cases on gender, 5-year age-
group, and residence area. In the other countries,
hospital controls with a diagnosis other than cancer, in-
fectious diseases, and immunodeficiency were recruited.
Overall, the data base included 2362 cases and 2465
controls who participated in the study. We excluded 14
cases as the diagnosis was not confirmed, and three con-
trols because of missing work history. We also reclassi-
fied one case as a control, and excluded another case
because of missing data on core variables, which resulted
in 2346 cases and 2463 controls.
Local Ethics Committees approved the study protocol
in all the participating centers. Informed consent was
obtained from each participant. Overall, the participation
rate was 88% in cases, 81% in hospital controls and 52%
in population controls. Trained interviewers conducted
in-person interviews with cases and controls, using the
same standardized questionnaire translated to the local
language. Questionnaire information included socio-
demographics, lifestyle habits, such as alcohol drinking
and tobacco smoking, health history, and a lifetime oc-
cupational history. For each job entry in the occupa-
tional history lasting 1 year or longer, the questionnaire
included a short description of the type of business or
trade; the specific individual tasks, and the tools used
were also inquired into. Finally, the interviewer submit-
ted to the study participant a checklist of risk factors of
a priori interest for self-report about exposure. In case
of occurrence of one or more exposure of interest, the
interviewer also submitted one or more of fourteen spe-
cific job modules to gather additional details on the ex-
posure circumstances. When planning the study,
however, ionizing radiation was not included among the
occupational exposures of interest.
Occupational exposure assessment
Industrial hygienists in each participating center coded
the work histories of study subjects using the 5-digit
1968 International Labour Organization Standard Classi-
fication of Occupations (ISCO68) [24], and the 4-digit
codes of the 1996 European Statistical Classification of
Economic Activities, revision 1 (NACE96) [25]. To as-
sess occupational exposure to ionizing radiation, distin-
guishing between external and internal radiation, we
developed a job-exposure matrix (JEM) based upon the
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list of ISCO68 and NACE96 codes. Exposure was classi-
fied according to the following exposure indicators:
– Dose of exposure to external and internal ionizing
radiation by job was abstracted from published
reports and surveillance data (see supplementary list
of references), and unpublished data bases of
monitoring data. For internal radiation, we first
identified the main radionucleide conveying
exposure in each job; secondly, to calculate the
committed effective dose (CED) for adults associated
with each radionucleide, we estimated the
appropriate quality factor (QF) based upon the
respective proportion of the different type of
radiation emitted (QF = 20 for α radiation; QF = 1
for β, γ and x radiation; QF = 5 for protons and
neutrons; a QF = 5 was assumed for neutrons in
absence of specific information on their energy level)
[4]; thirdly we applied the QF and the tissue
weighting factor for circulating blood cells, as
indicated in the BEIR VI report for radon [26].
Exposure was then categorized into four categories:
unexposed, low, medium, and high. As a cut-off for
exposure, we used the thresholds for the general
population, i.e. 1 mSv/year for exposure to external
radiation, or 20 mSv/year as a CED to the blood
cells for internal exposure to α-radiation,
correspondent to a dose equivalent of 1 mSv for
radon [27]. A high exposure level was defined
when available surveillance data suggested equiva-
lent doses potentially equal to or above 6 mSv/
year for external radiation, or to 44 mSv as a
CED to the blood cells, correspondent to the 100
Bq/m3 (average in one year) external radiation
level for radon at which lung cancer risk signifi-
cantly increases, as indicated at the point 22 of
the preamble of the EU Euratom Directive 2013/
59 [28]. The cut point between the low and
medium dose levels was arbitrarily set at 2.5 mSv,
or 30 mSv-year as a CED to the blood cells for
internal exposure to α-radiation. Jobs considered
as benchmarks for each level were used as refer-
ence for occupations for whom no surveillance
data were available.
– Probability of exposure: this metric was based on the
proportion of the exposed within the occupational
or the industrial code, with the following cut points:
less than 20%, 21–80%, and more than 80%. Based
on such cut points, we categorized probability of
exposure into four categories: unexposed, possible,
probable, and definite,
The dose and probability estimates associated with
some occupational and industry codes were adapted in
consideration of time and spatial changes in regulatory
legislation and technology:
1. The probability estimate for power plant operators
(ISCO68 code 96100) was differentiated by country,
as a function of the proportion of energy from
nuclear power plants [29]:
– high probability: France (100% of electric power
from nuclear fuel);
– medium probability: Germany, Spain, Czech
republic (30–50% of electric power from nuclear
fuel);
– unexposed: Italy, Ireland (0% of electric power from
nuclear fuel).
2. The estimate of potential dose in medical x-ray
technicians (ISCO68 codes 07700 and 07710), and
other medical, dental, veterinary and related
workers (ISCO68 code 07990), was modulated by
years of holding the job, considering the progressive
reduction in exposure as a result of regulatory
legislation over the time [30, 31]:
– high doses, if job started before 1975;
– medium doses, if job was initiated between 1975 and
1984;
– low doses, if job started from 1985 onwards.
3. Both, the dose and probability estimates for
protective service workers, not elsewhere classified
(ISCO68 code 58900), and mail sorting clerks
(ISCO68 code 37020) was modulated by the
approximate year of initiating use of x-rays in
screening baggage, personal belongings, and mail:
– no exposure, if job started before 2002 in post office
clerks, and before 1995 in airport security officers;
– low dose and probability, if job started from 2002
onwards for post office clerks, and from 1995
onwards for airport security officers. The low
probability category was set as the proportion of
airport security officers within the ISCO68 code
58900 was deemed to be lower than 20%.
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Measurements of external radiation doses in these
occupations have shown levels ranging 52–1820
micro Roentgen (μR) per hour, corresponding to an
annual dose up to 0.3 mSv, well below the threshold
of 1 mSv/year [32], which explains why these
workers are usually not considered as occupationally
exposed, and thus are not required to wear a
dosimeter. We decided nonetheless to include this
additional occupational source, as it would add to
the background radiation level.
Baggage control personnel in ship boarding was con-
sidered as unexposed, as the use of x-rays for screening
baggage and personal belongings before allowing board-
ing onto ships was introduced when recruitment of
study subjects was approximately completed.
The estimated dose and probability of exposure for
each study subject was calculated as the time weighted
average of the respective estimates for each job entry in
his/her work history. The lifetime weighted average
doses were finally categorized as described above. Cu-
mulative exposure to external or internal ionizing radi-
ation for each individual was obtained as the sum of the
products of the dose estimate associated to each job
entry times its duration in years. For the purposes of
analysis, cumulative doses were categorized into tertiles
based on the distribution among the controls.
Due to the small number of subjects in the high cat-
egory of exposure to external and internal radiation, in
conducting the analysis, we combined the medium and
high probability categories, and the medium-high cat-
egories of average dose of exposure, and we used the
median as the cut point between increasing cumulative
exposure categories.
Statistical methods
The Odds Ratio (OR) and its 95% confidence interval
(CI) of lymphoma (all subtypes combined), B-cell lymph-
oma, and its most prevalent subtypes, namely diffuse
large B cell lymphoma (DLBCL), CLL including small
lymphocytic lymphoma (CLL/SLL), follicular lymphoma
(FL), multiple myeloma (MM), and Hodgkin Lymphoma
(HL), were calculated using unconditional logistic re-
gression and polytomous logistic regression analysis. We
conducted separate analyses for exposure to external
and internal ionizing radiation; to single out the effects
of the two different types of ionizing radiation, we ex-
cluded 70 subjects (27 cases and 43 controls) exposed to
internal radiation from the unexposed to external radi-
ation, and 410 subjects (190 cases and 220 controls) ex-
posed to external radiation from the unexposed to
internal radiation. We coded separately 18 subjects ex-
posed to both types of radiation, so to inquiry into ef-
fects resulting from their sum. Therefore, we conducted
the analysis for external radiation on 2319 cases and
2420 controls, and that for internal radiation on 2156
cases and 2243 controls. We looked at each exposure
metric individually, i.e. we did not combine probability
and dose of exposure in the same exposure metric, nor
included them together in the same model. The ration-
ale for such decision was to explore the association from
two different perspectives, so to increase the strength of
inference. All models included age, gender, education,
and study center as the adjusting covariates. Heterogen-
eity in risk across lymphoma subtypes was assessed with
the Cochrane Q test.
The test for linear trend across categories of the ex-
posure metrics was calculated using the Wald statistics
after continuous transformation of the covariates in the
logistic model. We set the two-tailed α-error threshold
to reject the null hypothesis at p < 5%. All the analyses
were conducted with SPSS® version 20.0.
Results
Mean age was substantially similar for cases and controls
(cases: 56.1 years, sd 16.2;controls: 56.2 years, sd 16.0),
and by gender (men: 56.0 years, sd 15.8; women: 56.3
years, sd 16.4).The male/female ratio among the cases
was 1.3:1, consistent with the existing literature [33].
Table 1 shows the distribution of cases and controls by
participating center and by selected variables.
Having ever being occupationally exposed to external
ionizing radiation was not associated with risk of lymph-
oma (all subtypes combined; OR = 0.9; 95% CI 0.73,
1.08); the result was likewise after restricting the analysis
to B-cell lymphomas (OR = 0.9; 95% CI 0.75, 1.14)
(Table 2a). Risk estimates did not increase by cumulative
exposure, duration, or maximum or average intensity of
exposure, nor did they increase after limiting the analysis
to the categories of probable and definite exposure to
cumulative doses above 15.4 mSv-years (lymphoma, any
subtype: OR = 1.0, 95% CI 0.51, 2.06; based on 16 ex-
posed cases and 16 exposed controls; B-cell lymphoma:
OR = 1.0, 95% CI 0.48,2.12; based on 13 exposed cases
and 16 exposed controls), with no upward trend de-
tected (p for trend = 0.89 and 0.97, respectively). No as-
sociation was observed between risk of lymphoma (all
subtypes combined) or B-cell lymphomas and exposure
to internal radiation (Table 2b). Note that numbers of
cases and controls in Table 3a and b differ because of
the exclusion of subjects exposed to internal radiation
from the unexposed to external radiation (Table 2a), and
of subjects exposed to external radiation from the ex-
posed to internal radiation (Table 2b).
Table 3 shows the results by lymphoma subtype. The
number of the exposed was very small for each subtype,
particularly in the high dose and high probability cat-
egories of exposure. None of the lymphoma subtypes we
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analyzed showed an association with ever exposure to
external ionizing radiation. For external radiation, the
statistical power was not enough to detect as significant
the increase in risk of DLBCL associated with probable/
definite exposure (OR = 1.6, 95% CI 0.80, 3.40), prob-
able/definite exposure to estimated average doses ≥2.6
mSv (OR = 2.3; 95% CI 0.90, 5.84; based on seven cases
and 13 controls), and probable/definite exposure to cu-
mulative doses above 15.5 mSv-years (OR = 1.6; 95% CI
0.71, 3.46; based on seven cases and 16 controls), with
no trend detected by both exposure metrics (p = 0.09,
and p = 0.16, respectively). Chance most likely explained
the moderate increase in the risk estimate for follicular
lymphoma associated with duration of exposure above
the median among subjects with probable/definite ex-
posure (OR = 2.4, 95% CI 0.76, 7.41), probable/definite
exposure to average doses ≥2.6 mSv (OR = 1.4, 95% CI
0.32, 6.58), and cumulative doses ≥15.4 mSv-years (OR =
1.6, 95% CI 0.71, 3.46), with no upward trend detected
(p = 0.28, p = 0.55, and p = 0.28, respectively). A sporadic
excess risk of Hodgkin lymphoma associated with prob-
able/definite exposure to average doses above 2.6 mSv
(OR = 2.0, 95% CI 0.59, 6.81) was also interpreted as a
chance finding.
Internal doses from occupational exposure did not
show an association with risk of any of the major lymph-
oma subtypes (Table 3b). For all the subtypes, risks asso-
ciated with the exposure metrics were below or around
unity in all cells, with no heterogeneity detected (Q =
4.31, p = 0.366). An analysis restricted to subjects ex-
posed to both internal and external radiation also did
not show an association (not shown in the Tables).
Discussion
According to our assessment, in our population based
case-control study, 10.1% study subjects were ever ex-
posed to external ionizing radiation, but only for 1.2%
exposure was probable or definite. The proportion of
study subjects exposed to internal ionizing radiation was
even lower. Under such circumstances, we could only
have enough statistical power to detect risks of
lymphoma (all subtypes combined) of 2.05 or greater.
Therefore, in spite of its large size, our study was under-
powered to provide evidence of an association between
low-level occupational exposure to external or internal
ionizing radiation and risk of lymphoma subtypes. The
increasing risk of DLBCL, observed in with different ex-
posure metrics among subjects with probable/definite
exposure would warrant further investigation before dis-
carding it as a chance finding. We did not find evidence
of an association between exposure to internal radiation,
which, in occupational settings, is mostly due to inhal-
ation of α-radiation, and risk of any of the lymphoma
subtypes most frequently represented among our cases.
Previous cohort studies found an increase in NHL risk
following exposure to external ionizing radiation in the
aftermath of the Hiroshima and Nagasaki bombings [6,
12, 33] or following radiotherapy [3]. On the other hand,
findings were contradictory when occupational expo-
sures were considered [5, 8]. HL incidence and mortal-
ity, and NHL incidence were associated with cumulative
dose of external radiation among workers at the Springs-
field uranium production facility [34]. Also, mortality
from lymphatic and hematopoietic malignancies other
than leukemia was elevated in a cohort study of seven
Colorado uranium mills (SMR = 1.44; 95% CI 0.83–2.35),
due to excess cases of lymphoma, Hodgkin and non-
Hodgkin [35]. Risk of CLL, HL, and NHL, were also ele-
vated in other cohort studies of uranium and non uran-
ium miners in relation to exposure to γ radiation [36,
37], and in recent studies of Chernobyl cleanup workers
with prolonged exposure to low-dose external ionizing
radiation [13, 14], while MM results were conflicting
[13, 14, 38, 39]. However, studies of uranium miners and
millers are difficult to interpret because of the small co-
hort size, the lack of measurements or estimates of
Table 1 Distribution of cases and controls by gender, area of
study, education level, and ever exposure to external and
internal sources of ionizing radiation
Cases
(N = 2346)
Controls
(N = 2463)
N % N %
Gender
Male 1313 55.97 1321 53.63
Females 1033 44.03 1142 46.37
Area of recruitment
Spain 591 25.19 631 25.62
France 298 12.70 276 11.21
Germany 703 29.97 710 28.83
Italy 262 11.17 336 13.64
Ireland 201 8.57 207 8.40
Czech Republic 291 12.40 303 12.30
Education level
Elementary/middle school 1078 45.95 1122 45.55
High school 937 39.94 1001 40.64
University degree 331 14.11 340 13.81
Ever occupationally exposed to ionizing radiation
External radiation 224 9.66a 255 10.53a
Internal radiation 37 1.72b 54 2.23b
External and internal radiation 8 0.34a 10 0.41a
Notes: a Percentage over the 2319 cases and 2422 controls included in the
analysis of external radiation
b Percentage over the 2156 cases and 2245 controls included in the analysis of
internal radiation
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internal doses, and by the use of surrogates for cumula-
tive exposure to uranium. In fact, unavailability of his-
torical monitoring data reflects a common drawback of
many retrospective studies, including those conducted in
uranium miners and millers [39]. Some studies also re-
ported a link with internal exposure resulting from
inhalation of radon gas and its rapidly decaying α-
emitting daughters, exhaling from the porosity of the
rocks, and not diluted by an efficient ventilation system
[36, 39]. Previous large surveys contradict such reports
[7, 8]. Besides, the International Agency of Research on
Cancer classified uranium in group 3 (not classifiable),
Table 2 OR and 95% CI for lymphoma (all subtypes combined) and B-cell lymphomas in relation to dose and probability of
exposure to external (A) and internal (B) ionizing radiation
(A) external radiation and (B) interal radiation All lymphomas
(N = 2319)
B-cell lymphomas
(N = 1907)
cases/controls OR 95%CI cases/controls OR 95%CI
(A)
Unexposed 2095/2164 1.0 – 1730/2164 1.0 –
Ever exposed 224 /255 0.9 0.73–1.08 177/255 0.9 0.75–1.14
Average probability
Possible 199/228 0.9 0.73–1.08 156/228 0.9 0.74–1.15
Probable/definite 25/27 0.9 0.53–1.60 21/27 0.9 0.52–1.69
Average dose
1–2.5 mSv 103/121 0,8 0.62–1.08 85/121 0.9 0.65–1.16
≥ 2.6 mSv 121/134 1.0 0.74–1.24 92/134 1.0 0.74–1.30
≥ 2.6 mSv, probable/ definite exposure 16/13 1.3 0.60–2.64 12/13 1.2 0.53–2.60
Duration of exposure
≤ 11 years 116/131 0.9 0.68–1.15 85/131 0.9 0.68–1.21
≥ 12 years 108/124 0.9 0.68–1.17 92/124 0.9 0.71–1.25
Cumulative exposure
1.75–15.39 mSv-years 119/126 0.9 0.72–1.21 90/126 1.0 0.72–1.27
> 15.4 mSv-years 105/129 0.9 0.65–1.11 87/129 0.9 0.68–1.19
Probable/definite exposure
≥ 15.4 mSv-years 16/16 1.0 0.51–2.06 13/16 1.0 0.48–2.12
All lymphomas
(N = 2186)
B-cell lymphomas
(N = 1700)
cases/controls OR 95%CI cases/controls OR 95%CI
(B)
Unexposed 2149/2164 1.0 – 1669/2164 1.0 –
Ever exposed 37/54 0.7 0.43–1.02 31/54 0.7 0.45–1.12
Average probability
Possible 13/22 0.6 0.28–1.12 11/22 0.6 0.31–1.33
Probable/definite 24/32 0.7 0.39–1.11 20/32 0.8 0.43–1.34
Average intensity
1–2.5 mSv 35/30 1.2 0.70–1.90 29/30 1.1 0.65–1.85
> 2.5 mSv 2/24 0.1 0.02–0.31 2/24 0.1 0.03–0.50
Duration of exposure
≤ 8 years 24/27 0.9 0.49–1.50 19/27 0.9 0.50–1.65
≥ 9 years 13/27 0.5 0.24–0.91 12/27 0.5 0.26–1.04
Cumulative exposure
≤ 30mSv-years 21/25 0.8 0.45–1.46 18/25 0.9 0.50–1.71
> 30 mSv-years 16/29 0.5 0.29–1.00 13/29 0.5 0.27–1.03
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and it did not include NHL or CLL among the neoplas-
tic diseases induced by exposure to α radiation [38].
Apart from a few exceptions, previous studies consid-
ered all lymphomas as a unique disease entity, or at
most made a distinction between Hodgkin and non-
Hodgkin lymphomas. However, recent collaborative
studies from the InterLymph Consortium have shown
etiological heterogeneity across lymphomas in terms of
occupational risk factors, lifestyle habits, health history,
and individual characteristics [40]. Therefore, if only a
few lymphoma subtypes were radiosensitive, dilution of
the association with the relevant outcome might explain
previous contradictory findings.
Besides the generic definition of the disease entity,
random fluctuation of the risk estimates and/or expos-
ure misclassification might explain the lack of a consist-
ent link between exposure to ionizing radiation and
lymphoma. Using a JEM to retrospectively assess occu-
pational exposures in population-based studies conveys
a certain degree of exposure misclassification in respect
to the gold standard of available monitoring data. A re-
duction in sensitivity is expected as a JEM might not
cover the whole spectrum of jobs implying possible
penetration of ionizing radiation into the organisms
through different routes; specificity might be even more
reduced as the job codes, and not the individual mea-
surements, are the units to classify exposure. We tried to
minimize the consequences of exposure misclassifica-
tion, by designing our JEM a priori on the list of the
ISCO68 and the NACE96 codes, and by applying it sub-
sequently to the consistently coded work histories of
study subjects. Any misclassification affecting our find-
ings, therefore, might have been non differential between
cases and controls, and its effect would have been to-
wards a dilution of the true association and an under-
estimate of the true risk, if any. Also, we refrained from
lumping together different exposure metrics, such as in-
tensity and probability, as we endorse the opinion that
such strategies would result in both systematic and dif-
ferential measurement errors [41].
Other JEMs are available for the assessment of expos-
ure to ionizing radiation, such as the job-exposure
matrix for exposure to carcinogens initially developed by
the Finnish Institute of Occupational Health (FINJEM).
FINJEM is a development of the EU CAREX (CARcino-
gen EXposure) system, the job-exposure matrix for ex-
posure to carcinogens initially developed by the Finnish
Institute of Occupational Health with the support from
the International Agency for Research on Cancer, and
subsequently adapted to studies in numerous world
countries [42, 43]. However, FINJEM classifies exposure
to radon decay products, but not α radiation overall.
The Canadian version of CAREX, also widely used, does
not discriminate between types of radiation, and both
FINJEM and CAREX are based on occupational codes
only, which could lead to some loss of information, diffi-
cult to quantify. For these reasons, we did not rely on
the existing JEMs, and developed instead our own JEM.
An attempt to combine the assessments from the vari-
ous existing JEMs to come up with more robust esti-
mates will be pursued in the near future.
A further limitation in interpreting our findings is re-
lated to the multiple comparisons we made, which gen-
erated the random fluctuations of the risk estimates we
observed in some subsets.
Apart from chance, we do not have a clear explanation
of the inverse association between risk of lymphoma and
its subtypes and the exposure metrics of internal radi-
ation doses. Several limitations in our study might have
played a role. First, the conditions inside workplaces
may vary, and they may affect the equilibrium, for in-
stance between radon and its decay products, and there-
fore the exposure. However, we did not have the
necessary information to include such source of vari-
ation in our estimated by occupation and industry. Sec-
ond, the size of particles engulfing the α-emitting
radioisotope, typically radon and its decay products, may
vary between underground and open air mines and
quarries, with smaller particles more likely to penetrate
the deep lung and to deliver larger doses to the lungs
and the other internal organs. Particle size would be
smaller in mines; however, lymphoma risk associated
with underground mining in our study was also reversed
(OR = 0.7; 95% CI 0.55, 0.96; not shown in the Tables),
which would undermine an effect of particle size in
masking an association with internal radiation exposure
in our study.
Third, in the general population, exposure during
diagnostic procedures is a major source of external dose
of ionizing radiation, which we did not consider in our
paper. Another paper used the same data base as in our
study to investigate the association between cumulative
doses of ionizing radiation from diagnostic procedures
in relation to risk of lymphoma (Pasqual E et al. submit-
ted): the median cumulative dose at the bone marrow
level was 2.25 mGy, much below the estimated median
cumulative dose among the exposed to external ionizing
radiation in our study, and there was no association with
risk of lymphoma. Also, there is no plausible reason to
suspect that cases in our study had less radiodiagnostic
procedures in respect to the controls, It seems therefore
unlikely that exposure from diagnostic procedures might
have acted as a confounder in our study.
Conclusions
In conclusion, our results did not show an association of
lymphoma risk with low level occupational exposure to
ionizing radiation, either external or internal, within the
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current standards. Occupational exposure to radiation as
a possible cause of lymphoma subtypes warrants further
investigation with larger data sets. Pooled analyses of
large case-control studies would be particularly suitable
to test whether the range of haemopoietic malignancies
related to exposure to ionizing radiation should be ex-
tended to cover also specific lymphoma subtypes.
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